Sleep and EEG biomarkers as avenues toward new treatment approaches in Angelman syndrome

Neuropsychopharmacology. 2020 Jan;45(1):238-239. doi: 10.1038/s41386-019-0517-2.
No abstract available

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angelman Syndrome / genetics
  • Angelman Syndrome / physiopathology*
  • Angelman Syndrome / therapy
  • Electroencephalography / methods*
  • Epilepsy / genetics
  • Epilepsy / physiopathology
  • Epilepsy / therapy
  • Humans
  • Randomized Controlled Trials as Topic / methods
  • Sleep / physiology*
  • Sleep Wake Disorders / genetics
  • Sleep Wake Disorders / physiopathology*
  • Sleep Wake Disorders / therapy
  • Treatment Outcome